Skip to main content

IMMUTEP Ltd

IMMP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001506184

No open-market purchases or sales by IMMUTEP Ltd insiders were filed in the last 90 days; 25 institutions reported holding it in 13F filings for Q2 2026, worth $692.0K in total; no superinvestor holds it.

Other share classesPRRUF

Q2 2024 vs. Q1 2024

How the institutions holding IMMUTEP Ltd changed between Q1 2024 and Q2 2024.

All holders in Q2 2024All holders in Q1 2024

13F holders of IMMP: Q1 2024 compared with Q2 2024
MeasureQ1 2024Q2 2024Change
Holders2328+5
Shares2.32M2.41M+89.3K (+3.8%)
Value$5.40M$4.84M−$562.8K (−10.4%)

New holders (8)

Institutions that held IMMUTEP Ltd at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to IMMP in Q2 2024
InstitutionSharesValue% of portfolio
Meridian Wealth Management, LLC381,200$766.2K0.09%
Jane Street Group, LLC125,582$252.4K0.00%
Old Mission Capital LLC113,037$227.2K0.01%
XY Capital Ltd52,005$104.5K0.12%
LPL Financial LLC29,332$59.0K0.00%
XTX Topco Ltd12,958$26.0K0.00%
Ronald Blue Trust, Inc.353$8220.00%
Advisor Group Holdings, Inc.38$760.00%

Sold out (3)

Institutions that held IMMUTEP Ltd at the end of Q1 2024 and filed for Q2 2024 without it.

Institutions that sold out of IMMP in Q2 2024
InstitutionShares, Q1 2024Value, Q1 2024
Oracle Investment Management Inc564,879$1.32M
Eagle Strategies LLC22,800$53.1K
JPMorgan Chase & Co1,753$4.08K